Janux Therapeutics
JANX
JANX
174 hedge funds and large institutions have $1.59B invested in Janux Therapeutics in 2025 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 64 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.17% less ownership
Funds ownership: 110.61% → 108.44% (-2.2%)
11% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 64
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
174
Holding in Top 10
3
Calls
$14.6M
Puts
$5.39M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$13.6M | |
| 3 | +$12.3M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.2M |
| 5 |
BlackRock
New York
|
+$8.02M |
Top Sellers
| 1 | -$34M | |
| 2 | -$15.9M | |
| 3 | -$12.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10.5M |
